share_log

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright & Co.重申买入compass therapeutics,并维持10美元的价格目标。
Benzinga ·  08/12 14:22  · 评级/大行评级

HC Wainwright & Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 price target.

HC Wainwright&Co.的分析师Joseph Pantginis重申了买入并维持10美元的价格目标,原文提到了Compass Therapeutics(纳斯达克:CMPX)。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发